Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. scores highest on Torque (76) and lowest on Nitro (22). Its PosiPenta is 47.41 out of 100, around the middle of similar companies.
On the Penta Grid this week, Sumitomo Pharma Co., Ltd. is Grid #34 of 48 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Details
PPrice
| P/E ratio | 8.15 |
| P/B ratio | 2.14 |
EEarnings
| Trailing EPS | ₹144.48 |
| Forward EPS | ₹10.37 |
NNitro
| Price | 1178.04 |
| 52-week high | 1990.44 |
| 52-week low | 719.17 |
| Fall from 52-week high | 40.8% |
TTorque
| Return on equity (ROE) | 38.53% |
| Debt-to-equity | 0.39 |
AAnchor
| Beta (price swings) | 0.47 |
| Market cap | ₹52,846 Cr |
| Insider holding | 48.83% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Sumitomo Pharma Co., Ltd.'s PosiPenta score?
Sumitomo Pharma Co., Ltd.'s PosiPenta is 47.41 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Sumitomo Pharma Co., Ltd. stand on the Penta Grid?
On the Penta Grid this week, Sumitomo Pharma Co., Ltd. is Grid #34 of 48 in Japan.
Which PosiPenta pillar is strongest for Sumitomo Pharma Co., Ltd.?
Torque (durability), with a score of 76 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Sumitomo Pharma Co., Ltd.?
Nitro (momentum), with a score of 22 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.